Area of research
Oncology · Cancer Research
Research interest
Research focused on Gemcitabine and Metformin, with related work in Fibroblast growth factor receptor, Sorafenib, Cancer. Notable publications include 'Repurposing metformin for cancer treatment: current clinical studies', 'Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application', and 'SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers'.
SWOG S1815: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced Biliary Tract Cancers
SWOG 1815: A phase III randomized trial of gemcitabine, cisplatin, and nab-paclitaxel versus gemcitabine and cisplatin in newly diagnosed, advanced biliary tract cancers.
Comparing Real World, Personalized, Multidisciplinary Tumor Board Recommendations with BCLC Algorithm: 321-Patient Analysis
Immuno-oncology and Its Opportunities for Interventional Radiologists: Immune Checkpoint Inhibition and Potential Synergies with Interventional Oncology Procedures
Repurposing metformin for cancer treatment: current clinical studies
Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application